Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients

Fibroblast growth factor receptor (FGFR) genomic alterations (GAs) represent an actionable target, key to the pathogenesis of some urothelial cancers (UCs). Though FGFR GAs are common in noninvasive UC, little is known about their role in the metastatic(m) setting and response to therapy. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevillano Fernández, Elena, Madurga de Lacalle, Rodrigo, Rodriguez Moreno, Juan Francisco, Barquín García, Arantzazu, Yagüe Fernández, Mónica, Navarro Alcaraz, Paloma, Barba Llacer, María, Quiralte Pulido, Miguel, García-Donás Jiménez, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369263/
https://www.ncbi.nlm.nih.gov/pubmed/35956100
http://dx.doi.org/10.3390/jcm11154483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369263/
https://www.ncbi.nlm.nih.gov/pubmed/35956100
http://dx.doi.org/10.3390/jcm11154483

Ejemplares similares